Welcome to our dedicated page for Bausch & Lomb SEC filings (Ticker: BLCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bausch & Lomb's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bausch & Lomb's regulatory disclosures and financial reporting.
KAVANAGH SARAH B reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Sarah B. Kavanagh received an equity grant of 15,842 common shares-equivalent on an award date price of $15.78 per share. The grant reflects annual restricted share units for non-employee directors under the company’s 2022 Omnibus Incentive Plan.
The RSUs are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders and will be settled in common shares. Following this award, Kavanagh directly holds 69,541 common shares, highlighting this as compensation-related rather than an open-market purchase.
COLLIS STEVEN H reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Steven H. Collis received an equity award rather than buying shares on the market. He was granted 15,842 common-share-equivalent restricted share units (RSUs) valued at $15.78 per unit, bringing his direct holdings to 42,003 common shares after the award.
The RSUs were granted as the annual award to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. They are scheduled to vest on the date immediately before the company’s next annual meeting of shareholders, when they will be settled in common shares.
Bernier Nathalie D. reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Nathalie D. Bernier received an annual equity award in the form of restricted share units (RSUs). She was granted 15,842 common shares at a reference price of $15.78 per share, increasing her direct holdings to 85,505 common shares.
The footnote explains this is the regular annual RSU grant to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. These RSUs will vest immediately before the next annual meeting of shareholders and will then be settled in common shares.
Alfonso Eduardo reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Alfonso Eduardo received an equity award linked to 15,842 common shares of the company. The Form 4 shows this as a grant or award, not an open-market purchase, at a reference price of $15.78 per share. This reflects his annual grant of restricted share units under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan for non-employee directors. The RSUs will be settled in common shares and are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders. Following this award, Eduardo directly holds 31,072 common shares.
Bausch & Lomb Corp Chairman and CEO Brent L. Saunders reported a routine tax-related share disposition. On May 22, 2026, 2,886 common shares at $15.92 per share were withheld to satisfy tax withholding obligations upon vesting of restricted share units. After this non-market transaction, Saunders directly holds 978,389 common shares, so the withheld amount represents only a small portion of his overall position.
Bausch + Lomb Corporation reported the results of its Annual Meeting of Shareholders held on May 20, 2026. Shareholders elected ten directors, including Eduardo Alfonso and Brenton L. Saunders, with each nominee receiving over 331 million votes in favor and around 4.2 to 4.3 million votes against, plus 11.45 million broker non-votes.
Shareholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 328,089,056 votes for, 832,221 against, 6,896,414 abstentions and 11,452,072 broker non-votes. In addition, shareholders appointed PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm until the close of the 2027 annual meeting, with 343,283,263 votes for and 3,986,500 votes withheld.
Bausch & Lomb Corp EVP and CFO Sam Eldessouky reported a tax-related share disposition. On May 5, 2026, 63,938 common shares were withheld at $16.00 per share to satisfy tax withholding obligations upon vesting of restricted share units. This was not an open-market sale. After this withholding, Eldessouky directly holds 343,192 common shares of Bausch & Lomb Corp.
Bausch & Lomb Corp executive Yehia Hashad, EVP of R&D and CMO, reported a routine tax-related share disposition on Form 4. On May 5, 2026, 13,664 common shares at $16.00 per share were withheld to cover tax obligations triggered by the vesting of restricted share units, rather than sold in the open market. After this withholding, Hashad directly holds 166,377 common shares, indicating he retains a substantial equity stake in the company.
Bausch & Lomb Corp senior vice president, controller and chief accounting officer Frederick Munsch reported a routine share disposition related to taxes. On May 5, 2026, 8,673 Common Shares at $16.00 per share were withheld to cover tax obligations upon vesting of restricted share units, rather than sold on the open market.
After this tax-withholding event, Munsch directly holds 89,640 Common Shares. The filing reflects a compensation-related withholding, not an open-market purchase or sale decision.
Bausch & Lomb Corp executive Luc Bonnefoy, President of Surgical, reported a routine tax-related share disposition. On the vesting of restricted share units, 11,970 common shares were withheld by the company to satisfy tax withholding obligations, rather than sold on the open market. Following this withholding, Bonnefoy directly holds 88,031 common shares, showing he retains a substantial equity position after the RSU vesting event.